CHGA and neoplasm: Sellar tumor samples were consistently immunoreactive for neuroendocrine markers chromogranin A (Fig. 3c), synaptophysin (Fig. 3d), CD56/NCAM (Fig. 3e), and S100 (Fig. 3f), further supporting a pituitary NET classification36,41,42.